期刊文献+

修复交叉互补基因1基因单核苷酸多态性与弥漫大B淋巴瘤发病风险及亚型的相关性

下载PDF
导出
摘要 目的探讨修复交叉互补基因(ERCC)1单核苷酸多态性与弥漫大B淋巴瘤(DLBCL)发病风险及亚型的相关性。方法 DLBCL患者108例,根据病理亚型分为活化B细胞型组(ABC组)和生发中心型组(GCB组)各54例。另选取同期该院体检中心体检的健康人群54例作为对照组,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行ERCC119007 T>C和ERCC18092 C>A位点多态性检测,分析ERCC1基因单核苷酸多态性与DLBCL发病风险及亚型的相关性。结果 3组ERCC1基因型中19007 T>C的TT和CT+CC分布频率差异有统计学意义(P<0.05),而8092 C>A的CC和CA+CC分布频率差异无统计学意义(P>0.05);4个单体型中2种单体型频率差异有统计学意义:单体型C-C-C降低了个体DLBCL患病的风险(OR=0.589,P=0.039),单体型T-C-T则提高了个体DLBCL患病的风险(OR=0.915,P=0.025);TT和CT基因型发生不同亚型DLBCL发病危险明显高于CC基因型,且高分化和高分期患者的CT+CC基因型分布频率高于低分化和低分期患者(P<0.05)。结论 ERCC1基因19007 T>C位点多态性与DLBCL发病风险及亚型发生发展密切相关,携带该基因2种不同单体型的个体在DLBCL发病风险及亚型患病风险上存在差异。
出处 《中国老年学杂志》 CAS 北大核心 2017年第6期1409-1411,共3页 Chinese Journal of Gerontology
基金 2014年厦门市科技计划科技惠民项目(No.3502Z20144003)
  • 相关文献

参考文献7

二级参考文献67

  • 1卢兴国,丛玉隆.应重视和提升传统血液形态学检验诊断水平[J].中华检验医学杂志,2006,29(6):481-482. 被引量:114
  • 2RN Zárate R,F Arias,E Bandres,E Cubedo,R Malumbres,J García-Foncillas.Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy[J].World Journal of Gastroenterology,2006,12(37):6032-6036. 被引量:7
  • 3Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haematopoietic and lymphoid tissues[M].4th ed.Lyon:IARC press,2008:14-367.
  • 4Zine G,Bain B,Bettelheim P,et,al.Short report[J].Br J Haematol,2010,151(4):359-364.
  • 5Jia Z, He J,Cen L,et al.P53 deletion is independently as- sociated with increased age and decreased survival in a co- hort of Chinese patients with diffuse large B-cell lympho- ma[J].Leuk Lymphoma, 2012,53 (11 ) : 2182-2185.
  • 6Swerdlow SH,Campo E, Harris NL,et al.WHO Classifi- cation of Tumors of Haematopietic and Lymphoid Tis- sues[M].Lyon : IARC Press, 2008 ; 233-268.
  • 7BD Cheson, SJ Homing, B Coiffier, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored Interna- tional Working Group [J]. J Clin Oncol, 1999, 17 (4) : 1244.
  • 8Hans CP, Weisenburger DD, Greiner TC, et al. Confirma- tion of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue mi- croarray[J].Blood, 2004,103(1) :275-282.
  • 9Winter JN, Weller EA, Homing S J, et al. Prognostic sig- nificance of Bcl-6 protein expression in DI.BCL treated with CHOP or R-CHOP: a prospective correlative study [J].Blood,2006,107(11) : 4207-4213.
  • 10Young K H, Leroy K, Moiler MB, et al. Structural profiles Of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study[J].Biood, 2008,112 (8) :3088-3098.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部